Valproic acid and HIV-1 latency: beyond the sound bite
- PMID: 16168066
- PMCID: PMC1242254
- DOI: 10.1186/1742-4690-2-56
Valproic acid and HIV-1 latency: beyond the sound bite
Abstract
A recent publication in Lancet by Dr. David Margolis and colleagues raised the prospect that HIV infection may be curable. In this pilot study, which received much attention from the press, Dr. Margolis'group found that valproic acid plus enfuvirtide reduces the pool of CD4+ T-cells, which are latently infected with HIV-1, the so-called viral reservoir. This commentary critically addresses current data on this topic.
Similar articles
-
Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes.Nat Med. 2007 Oct;13(10):1241-7. doi: 10.1038/nm1639. Epub 2007 Sep 30. Nat Med. 2007. PMID: 17906637
-
Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir.AIDS. 2008 Jun 19;22(10):1125-9. doi: 10.1097/QAD.0b013e3282fd6ddc. AIDS. 2008. PMID: 18525257
-
Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.J Virol. 2007 Sep;81(18):9693-706. doi: 10.1128/JVI.00492-07. Epub 2007 Jul 3. J Virol. 2007. PMID: 17609262 Free PMC article. Clinical Trial.
-
Latency: the hidden HIV-1 challenge.Retrovirology. 2006 Jan 16;3:7. doi: 10.1186/1742-4690-3-7. Retrovirology. 2006. PMID: 16412247 Free PMC article. Review.
-
Molecular mechanisms of HIV-1 proviral latency.Expert Rev Anti Infect Ther. 2005 Oct;3(5):805-14. doi: 10.1586/14787210.3.5.805. Expert Rev Anti Infect Ther. 2005. PMID: 16207172 Review.
Cited by
-
Hit-and-run stimulation: a novel concept to reactivate latent HIV-1 infection without cytokine gene induction.J Virol. 2010 Sep;84(17):8712-20. doi: 10.1128/JVI.00523-10. Epub 2010 Jun 10. J Virol. 2010. PMID: 20538859 Free PMC article.
-
Role of β-catenin/TCF-4 signaling in HIV replication and pathogenesis: insights to informing novel anti-HIV molecular therapeutics.J Neuroimmune Pharmacol. 2011 Jun;6(2):247-59. doi: 10.1007/s11481-011-9266-7. Epub 2011 Mar 8. J Neuroimmune Pharmacol. 2011. PMID: 21384147 Free PMC article. Review.
-
Kinase control prevents HIV-1 reactivation in spite of high levels of induced NF-κB activity.J Virol. 2012 Apr;86(8):4548-58. doi: 10.1128/JVI.06726-11. Epub 2012 Feb 15. J Virol. 2012. PMID: 22345467 Free PMC article.
-
Structure-optimized dihydropyranoindole derivative GIBH-LRA002 potentially reactivated viral latency in primary CD4+ T lymphocytes of chronic HIV-1 patients.Medchemcomm. 2017 Jul 25;8(9):1806-1809. doi: 10.1039/c7md00327g. eCollection 2017 Sep 1. Medchemcomm. 2017. PMID: 30108890 Free PMC article.
-
Plasmodium infection reduces the volume of the viral reservoir in SIV-infected rhesus macaques receiving antiretroviral therapy.Retrovirology. 2014 Dec 9;11:112. doi: 10.1186/s12977-014-0112-x. Retrovirology. 2014. PMID: 25487036 Free PMC article.
References
-
- Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, Quinn TC, Chadwick K, Margolick J, Brookmeyer R, Gallant J, Markowitz M, Ho DD, Richman DD, Siliciano RF. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science. 1997;278:1295–1300. doi: 10.1126/science.278.5341.1295. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials